4//SEC Filing
Benaim Ely 4
Accession 0001645113-22-000046
CIK 0001645113other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:30 PM ET
Size
6.6 KB
Accession
0001645113-22-000046
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-05-10$65.16/sh−2,070$134,877→ 36,981 total - Sale
Ordinary Shares
2022-05-11$61.25/sh−2,135$130,769→ 34,846 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Amended total to correct prior mathematical error.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:30 PM ET
- Size
- 6.6 KB